PB Jayakumar - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock PB Jayakumar's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
PB Jayakumar

PB Jayakumar

Verified

Senior Editor, Business Today (India)

Final Covers

Climate Change , Education Sector, Environmental issues, Rural Life, Kashmir Conflict

Doesn’t Cover

Medical and Forex

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 198

  • Covid-19 testing specialist Molbio Diagnostics eyes $1 billion revenue in 3-5 years

    By PB Jayakumar Verified| Business Today (India)@ Goa-based Molbio Diagnostics, which revolutionised India's Covid-19 screening with an innovative portable and battery-operated real-time RT PCR point of care (PoC) testing system, is eyeing to become a one-billion-dollar revenue company in the next 3-5 years, by globally selling 2-3 such disease surveillance platforms for various diseases. The Molbio Diagnostics' RT-PCR PoC testing system helps in detecting infection in remote and rural villages.

    By PB Jayakumar Verified · Business Today (India)

    Aug. 03, 2021

  • Krsnaa Diagnostics IPO to open on August 4; all you need to know

    By PB Jayakumar Verified| Business Today (India)@ Krsnaa Diagnostics Limited will open its initial public offering (IPO) on Wednesday, August 4. The price band is Rs 933 to Rs 954 per equity share of face value of Rs 5 each. The offer will close on Friday, August 6. This will be the fourth IPO to open on Wednesday, along with Devyani International, Windlas Biotech, and Exxaro Tiles. Minimum bid lot is 15 equity shares and in multiples of 15 equity shares, thereafter.

    By PB Jayakumar Verified · Business Today (India)

    Aug. 02, 2021

  • Covid-19 testing specialist Molbio Diagnostics eyes $1 billion revenue in 3-5 years

    By PB Jayakumar Verified| Business Today (India)@ Goa-based Molbio Diagnostics, which revolutionised India's Covid-19 screening with an innovative portable and battery-operated real-time RT PCR point of care (PoC) testing system, is eyeing to become a one-billion-dollar revenue company in the next 3-5 years, by globally selling 2-3 such disease surveillance platforms for various diseases. The Molbio Diagnostics' RT-PCR PoC testing system helps in detecting infection in remote and rural villages.

    By PB Jayakumar Verified · Business Today (India)

    Aug. 03, 2021

As seen in

Company Info

Business Today (India)